Content area

Abstract

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by deficits in executive functioning. Adults with ADHD suffer from academic and career performance issues and interpersonal difficulties disproportionate to their unaffected peers. However, there is growing evidence that ADHD may be connected to increased creative abilities. Creativity, a meaningful skill, can be applied across multiple settings and is often considered a personal strength. As several facets of creative processes are tied to some of the symptomatology of ADHD, it is essential to understand how the primary interventions for ADHD may impact creative cognitions. Psychostimulants, such as methylphenidate and amphetamines, tend to be the primary means of ADHD treatment, but the relationship between creativity and stimulant use remains unclear. From a neurocognitive perspective, it is critical to understand how a cognitive strength like creativity may be impacted by the primary means of treatment. There may be a great untapped potential for innovation and contributions of individuals with ADHD, allowing for decreased stigmatization and increased life/career satisfaction. The proposed study intends to add to existing literature supporting the connection between creativity and ADHD and explore the relationship between stimulant medication and creativity in adults with ADHD.Keywords: ADHD, adults, creativity, stimulant medication

Details

Title
Stimulant Medication and Creativity in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Author
Jones, Cydney; Fritz, Sarah; Davis, Dominique; Henkel, Zahra
Publication year
2023
Publisher
ProQuest Dissertations & Theses
ISBN
9798379637514
Source type
Dissertation or Thesis
Language of publication
English
ProQuest document ID
2822976971
Copyright
Database copyright ProQuest LLC; ProQuest does not claim copyright in the individual underlying works.